-
Product Insights
CHD – Old Fort Manufacturing Plant Expansion – Ohio
Equip yourself with the essential tools needed to make informed and profitable decisions with our CHD - Old Fort Manufacturing Plant Expansion - Ohio report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
CHD – Old Fort Cat Litter Manufacturing Capacity – Ohio
Equip yourself with the essential tools needed to make informed and profitable decisions with our CHD - Old Fort Cat Litter Manufacturing Capacity - Ohio report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Sector Analysis
Transcatheter Pulmonary Valve Replacement Market Size by Segments, Share, Regulatory and Reimbursement, Procedures and Forecast to 2033
Transcatheter Pulmonary Valve Replacement Market Report Overview The transcatheter pulmonary valve replacement market size was valued at USD 44.4 million in 2022. transcatheter pulmonary valve replacement/implantation (TPVR or TPVI) is indicated for patients with right ventricle outflow tract (RVOT) obstruction. These patients are most commonly infants with congenital heart disease  (CHD) which can present in multiple defects like Tetrology of Fallot, transposition of the great arteries, or pulmonary stenosis. These infants are born healthy, as they have relied on oxygenated...
-
Product Insights
Bioabsorbable Stents (BAS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
BAS Pipeline Products Market Report Overview Bioabsorbable stents are also known as bio-re-absorbable or biodegradable coronary stents. They are made from the material found in dissolvable sutures known as polylactic acid. The advantage of this stent is that it does not leave any metal body behind and hence, the possibility of late-stent thrombosis and restenosis decreases. Bioabsorbable stents help in better drug delivery compared to metallic stents. One unit refers to one bioabsorbable stent system. The BAS pipeline market research...
-
Product Insights
Haixing 1
Haixing 1 is a 1250MW nuclear power project located in Hebei, China. It is being developed by CNNC CHD Hebei Nuclear Power Corp. The project is currently in the permitting stage. The project is owned by China National Nuclear Power Co Ltd; Hebei Construction and Investment Group Co Ltd; Huadian Power International Corporation Ltd. Haixing 1 profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational...
-
Sector Analysis
Arteriotomy Closure Devices Market Size by Segments, Share, Regulatory and Reimbursement, Procedures and Forecast to 2033
Arteriotomy Closure Devices Market Report Overview The arteriotomy closure devices market size is valued at $766.9 million in 2022. Coronary Heart Disease (CHD) refers to narrowing of the coronary arteries due to inadequate supply of blood and oxygen. Decreased blood flow may cause angina (chest pain). Angina Pectoris (AP) denotes the presence of coronary artery disease (CAD) with an increased risk of a myocardial infarction (MI) also known as heart attack. Arteriotomy Closure Devices Market Overview 2022-2033 ($ Million) Â For...
-
Product Insights
Coronary Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Coronary Stents Pipeline Market Report Overview A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents. Coronary stent...
-
Product Insights
Haixing 2
Haixing 2 is a 1250MW nuclear power project located in Hebei, China. It is being developed by CNNC CHD Hebei Nuclear Power Corp. The project is currently in the permitting stage. The project is owned by China National Nuclear Power Co Ltd; Hebei Construction and Investment Group Co Ltd; Huadian Power International Corporation Ltd. Haixing 2 profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational...
-
Sector Analysis
Cardiac Catheters Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033
Cardiac Catheters Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Cardiac Catheters market for the year 2020 and beyond. Coronary Heart Disease (CHD) has emerged as a global burden on developing and developed countries. It refers to narrowing of the coronary arteries due to inadequate supply...
-
Sector Analysis
North America Cardiovascular Surgery Procedures Count by Segments (On-Pump Cardiac Surgery Procedures) and Forecast, 2015-2030
North America Cardiovascular Surgery Procedures Market Report Overview The total number of Cardiovascular Surgery Procedures conducted within North America was 384,197 in 2022. On-Pump Cardiopulmonary Bypass (CPB) is used in cardiac surgery to assist the patient's body's vital physiological processes while the heart is being operated on. This is particularly crucial and frequently required for surgical procedures such as coronary artery bypass surgery, the replacement and repair of heart valves, the correction of congenital heart abnormalities, and several vascular treatments....
-
Product Insights
![]()
Net Present Value Model: Pravachol
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Pravachol Drug Details Pravastatin sodium (Pravachol,...
-
Sector Analysis
Pulmonary Arterial Hypertension Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
Pulmonary Arterial Hypertension Market Overview The Pulmonary Arterial Hypertension (PAH) market size across the 7MM was valued at $4.6 billion in 2019 and is forecast to grow at a CAGR of more than 4% during 2019-2029. Pulmonary Arterial Hypertension Market Outlook To gain more information on the Pulmonary Arterial Hypertension market forecast, download a free report sample The Pulmonary Arterial Hypertension market research report provides an overview of PAH, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management. Market Size (2019)...
-
Sector Analysis
Pulmonary Arterial Hypertension – Epidemiology Forecast to 2029
Pulmonary arterial hypertension (PAH) is a rare, progressive disorder characterized by vascular proliferation and remodeling of the small pulmonary arteries (Humbert et al., 2004; Humbert et al., 2010; Simonneau et al., 2004). In PAH, blood vessels in the lungs are narrowed, blocked, or destroyed. The damage slows blood flow through the lungs (Mayo Clinic, 2020). This results in progressively increasing pulmonary vascular resistance, leading to an increase in pulmonary arterial pressure (Humbert et al., 2004, 2010; Simonneau et al., 2004)....
-
Sector Analysis
EpiCast Report: Pulmonary Arterial Hypertension – Epidemiology Forecast to 2024
PAH is a rare and severe condition characterized by vascular proliferation and remodeling of the small pulmonary arteries. This results in progressively increasing pulmonary vascular resistance, leading to an increase in pulmonary arterial pressure. The disease typically results in right-sided heart failure and premature death. PAH can be idiopathic, heritable, or associated with different conditions such as connective tissue disease (CTD), congenital heart disease (CHD), human immunodeficiency virus (HIV) infection, and exposure to toxins or drugs. PAH occurs twice as...
-
Sector Analysis
OpportunityAnalyzer: Pulmonary Arterial Hypertension – Opportunity Analysis and Forecasts to 2026
Pulmonary arterial hypertension (PAH) is a rare, fatal cardiopulmonary disease with an annual mortality rate of 15%. The disease is a subset (Group 1) within the World Health Organization’s (WHO’s) classification of the different types of pulmonary hypertension (PH). PAH is characterized by an abnormal rise in the resting mean pulmonary arterial pressure (>25mmHg compared with normal levels of around 14mmHg). This increased pressure is caused by pulmonary arterial obstruction due to endothelial dysfunction and vascular remodeling, and leads to...
-
Sector Analysis
EpiCast Report: Pulmonary Arterial Hypertension – Epidemiology Forecast to 2026
PAH is a rare and severe condition characterized by vascular proliferation and remodeling of the small pulmonary arteries. This results in progressively increasing pulmonary vascular resistance, leading to an increase in pulmonary arterial pressure. The disease typically results in right-sided heart failure and premature death To forecast the diagnosed incident and diagnosed prevalent cases of PAH in the 7MM, GlobalData epidemiologists selected nationally representative, registry-based studies and Ministry of Health statistics studies that provided the diagnosed incidence and/or diagnosed prevalence...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.